Abstract
Potent combination antiretroviral therapy (cART) has significantly improved the life expectancy of people living with human immunodeficiency virus (HIV), but it has many side effects such as lipodystrophy (LD), hepatic steatosis, and lactic acidosis. Nucleoside reverse transcriptase inhibitors (NRTIs) could damage the mitochondria by inhibiting the human DNA polymerase gamma, leading to mtDNA deletion. However, it remains uncertain whether NRTIs could induce the hypervariable region (HV) mutations of the D loop of mitochondria in Chinese HIV/AIDS patients, and whether that effect is different between individuals with and without LD. Hereby, 30 Chinese AIDS patients who were receiving antiretroviral drugs were recruited, among which 16 had symptomatic LD and 14 did not. Blood samples were collected prior to and after 96 weeks of treatment. Total DNA was extracted from peripheral blood mononuclear cells (PBMCs). Fragments of 728 bp in length containing HV2 were amplified by standard polymerase chain reaction (PCR). Direct DNA-sequencing analysis techniques were used to detect mitochondrial sequence variants between paired longitudinal samples. Alterations were compared with the revised Cambridge Reference Sequence (rCRS) to determine mutation or polymorphism. Results showed that two years after ART, totally seven cases exhibited sequence variations, ve individuals showed 73 → G revised variation (two with and three without LD), while two cases of LD were found to have other nucleotide alterations. There was no new alteration in individuals without LD. In conclusion, NRTIs could induce mutation of mtDNA HV2, which might contribute to the development of LD.
Similar content being viewed by others
References
Kohler J J, Lewis W. A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen, 2007, 48(3–4): 166–172
Wu Y, Li N, Zhang T, Wu H, Huang C, Chen D. Mitochondrial DNA base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine. Mutat Res, 2009, 664(1–2): 28–38
Andrews R M, Kubacka I, Chinnery P F, Lightowlers R N, Turnbull D M, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet, 1999, 23(2): 147
Anderson S, Bankier A T, Barrell B G, de Bruijn MH, Coulson A R, Drouin J, Eperon I C, Nierlich D P, Roe B A, Sanger F, Schreier P H, Smith A J, Staden R, Young I G. Sequence and organization of the human mitochondrial genome. Nature, 1981, 290(5806): 457–465
Barthelemy C, de Baulny H O, Lombes A. D-loop mutations in mitochondrial DNA: link with mitochondrial DNA depletion? Hum Genet, 2002, 110(5): 479–487
Martin A M, Hammond E, Nolan D, Pace C, Den Boer M, Taylor L, Moore H, Martinez O P, Christiansen F T, Mallal S. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors. Am J Hum Genet, 2003, 72(3): 549–560
McComsey G, Tan D J, Lederman M, Wilson E, Wong L J. Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy. AIDS, 2002, 16(4): 513–518
Weinberg J B, Muscato J J, Niedel J E. Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. J Clin Invest, 1981, 68(3): 621–630
Timmermans E C, Tebas P, Ruiter J P, Wanders R J, de Ronde A, de Baar M P. Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy. Clin Chem, 2006, 52(6): 979–987
Revised cambridge reference sequence (rCRS) of the human mitochondrial DNA. http://www.mitomap.org/MITOMAP/Human-MitoSeq
Crum-Cianflone N, Hullsiek K H, Marconi V, Weintrob A, Ganesan A, Barthel R V, Fraser S, Agan B K, Wegner S. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS, 2009, 23(1): 41–50
Mercier S, Gueye N F, Cournil A, Fontbonne A, Copin N, Ndiaye I, Dupuy A M, Cames C, Sow P S, Ndoye I, Delaporte E, Simondon K B. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study. J Acquir Immune Defic Syndr, 2009, 51(2): 224–230
Brinkman K, Smeitink J A, Romijn J A, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet, 1999, 354(9184): 1112–1115
Kakuda T N, Brundage R C, Anderson P L, Fletcher C V. Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy. AIDS, 1999, 13(16): 2311–2312
Shikuma C M, Hu N, Milne C, Yost F, Waslien C, Shimizu S, Shiramizu B. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS, 2001, 15(14): 1801–1809
McComsey G A, Paulsen D M, Lonergan J T, Hessenthaler S M, Hoppel C L, Williams V C, Fisher R L, Cherry C L, White-Owen C, Thompson K A, Ross S T, Hernandez J E, Ross L L. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS, 2005, 19(1): 15–23
Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS, 2003, 17(9): 1329–1338
McComsey G, Bai R K, Maa J F, Seekins D, Wong L J. Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion. J Acquir Immune Defic Syndr, 2005, 39(2): 181–188
Williams R S. Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J Biol Chem, 1986, 261(26): 12390–12394
Veltri K L, Espiritu M, Singh G. Distinct genomic copy number in mitochondria of different mammalian organs. J Cell Physiol, 1990, 143(1): 160–164
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, YS., Chen, XY., Shi, Y. et al. NRTIs’ effect on the sequence of mitochondrial DNA HV 2 in HIV infected patients. Front. Med. China 4, 177–184 (2010). https://doi.org/10.1007/s11684-010-0038-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-010-0038-1